Hanssen KF - Search Results

1

[Prevention of cardiovascular disease in type 2 diabetes].

Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I. Birkeland KI, et al. Among authors: hanssen kf. Tidsskr Nor Laegeforen. 2000 Sep 10;120(21):2554-9. Tidsskr Nor Laegeforen. 2000. PMID: 11070996 Review. Norwegian.

2

[Insulin treatment is of value--also in type 2 diabetes].

Birkeland KI, Vaaler S, Hanssen KF. Birkeland KI, et al. Among authors: hanssen kf. Tidsskr Nor Laegeforen. 1996 Apr 20;116(10):1233-5. Tidsskr Nor Laegeforen. 1996. PMID: 8658397 Norwegian.

3

[Type 2-diabetes consists of several diseases].

Hanssen KF, Birkeland KI, Thorsby P. Hanssen KF, et al. Tidsskr Nor Laegeforen. 1998 Mar 10;118(7):1025. Tidsskr Nor Laegeforen. 1998. PMID: 9531820 Norwegian. No abstract available.

4

[Treatment of non-insulin dependent diabetes (type 2 diabetes mellitus)].

Hanssen KF, Jenssen T. Hanssen KF, et al. Tidsskr Nor Laegeforen. 1992 Mar 10;112(7):912-4. Tidsskr Nor Laegeforen. 1992. PMID: 1557762 Norwegian.

5

[New diagnostic criteria for diabetes mellitus--why?].

Grill V, Claudi T, Følling I, Jenssen T, Hanssen K, Jervell J. Grill V, et al. Tidsskr Nor Laegeforen. 2000 Jun 20;120(16):1876-7. Tidsskr Nor Laegeforen. 2000. PMID: 10925616 Free article. Norwegian.

6

Insulin-mediated increase in calf blood flow is not related to blood pressure levels in patients with type 2 diabetes mellitus.

Birkeland KI, Hanssen KF, Stranden E, Falch JA, Vaaler S. Birkeland KI, et al. Among authors: hanssen kf. Blood Press. 1995 Mar;4(2):80-4. doi: 10.3109/08037059509077574. Blood Press. 1995. PMID: 7599758

7

A long-term, randomized, comparative study of insulin versus sulfonylurea therapy in type 2 diabetes.

Birkeland KI, Hanssen KF, Urdal P, Berg K, Vaaler S. Birkeland KI, et al. Among authors: hanssen kf. J Intern Med. 1994 Sep;236(3):305-13. doi: 10.1111/j.1365-2796.1994.tb00801.x. J Intern Med. 1994. PMID: 8077888 Clinical Trial.

8

NIDDM: a rapid progressive disease. Results from a long-term, randomised, comparative study of insulin or sulphonylurea treatment.

Birkeland KI, Rishaug U, Hanssen KF, Vaaler S. Birkeland KI, et al. Among authors: hanssen kf. Diabetologia. 1996 Dec;39(12):1629-33. doi: 10.1007/s001250050626. Diabetologia. 1996. PMID: 8960854 Clinical Trial.

9

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Kilhovd BK, Berg TJ, Birkeland KI, Thorsby P, Hanssen KF. Kilhovd BK, et al. Among authors: hanssen kf. Diabetes Care. 1999 Sep;22(9):1543-8. doi: 10.2337/diacare.22.9.1543. Diabetes Care. 1999. PMID: 10480523 Clinical Trial.

10

Heterogeneity of non-insulin-dependent diabetes expressed as variability in insulin sensitivity, beta-cell function and cardiovascular risk profile.

Birkeland KI, Kilhovd B, Thorsby P, Torjesen PA, Ganss R, Vaaler S, Hanssen KF. Birkeland KI, et al. Among authors: hanssen kf. Diabet Med. 2003 Jan;20(1):37-45. doi: 10.1046/j.1464-5491.2003.00838.x. Diabet Med. 2003. PMID: 12519318

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

197 results

Search Page